FDA clears XenoTherapeutics’ IND application; Massachusetts General Hospital designated as study center for first-in-human trials BOSTON–(BUSINESS WIRE)–December 7, 2018– XenoTherapeutics, a life ...
Few fields of medicine have seemed to hold more promise on the one hand and have engendered more controversy on the other than the field of xenotransplantation. The promise of xenotransplantation ...
BOSTON--(BUSINESS WIRE)--XenoTherapeutics, a life science company whose mission is to solve the global shortage of organs and tissues for transplants, announced today that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback